PLGA nanoparticles engineering extracellular vesicles from human umbilical cord mesenchymal stem cells ameliorates polyethylene particles induced periprosthetic osteolysis.


Journal

Journal of nanobiotechnology
ISSN: 1477-3155
Titre abrégé: J Nanobiotechnology
Pays: England
ID NLM: 101152208

Informations de publication

Date de publication:
31 Oct 2023
Historique:
received: 10 05 2023
accepted: 26 10 2023
medline: 1 11 2023
pubmed: 31 10 2023
entrez: 31 10 2023
Statut: epublish

Résumé

The wear particle-induced dissolution of bone around implants is a significant pathological factor in aseptic loosening, and controlling prosthetic aseptic loosening holds crucial social significance. While human umbilical cord mesenchymal stem cell-derived exosomes (HucMSCs-Exos, Exos) have been found to effectively promote osteogenesis and angiogenesis, their role in periprosthetic osteolysis remains unexplored. To enhance their in vivo application, we engineered HucMSCs-Exos-encapsulated poly lactic-co-glycolic acid (PLGA) nanoparticles (PLGA-Exos). In our study, we demonstrate that PLGA-Exos stimulate osteogenic differentiation while inhibiting the generation of reactive oxygen species (ROS) and subsequent osteoclast differentiation in vitro. In vivo imaging revealed that PLGA-Exos released exosomes slowly and maintained a therapeutic concentration. Our in vivo experiments demonstrated that PLGA-Exos effectively suppressed osteolysis induced by polyethylene particles. These findings suggest that PLGA-Exos hold potential as a therapeutic approach for the prevention and treatment of periprosthetic osteolysis. Furthermore, they provide novel insights for the clinical management of osteolysis.

Identifiants

pubmed: 37904168
doi: 10.1186/s12951-023-02177-7
pii: 10.1186/s12951-023-02177-7
pmc: PMC10617042
doi:

Substances chimiques

Polyethylene 9002-88-4
Glycols 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

398

Subventions

Organisme : the National Natural Science Foundation of China
ID : 81974339

Informations de copyright

© 2023. The Author(s).

Références

Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4954-4960
pubmed: 31210331
Life Sci. 2019 Sep 15;233:116733
pubmed: 31394127
J Clin Med. 2019 Dec 01;8(12):
pubmed: 31805704
Front Immunol. 2020 Aug 04;11:1720
pubmed: 32849609
Int J Nanomedicine. 2020 Nov 05;15:8641-8658
pubmed: 33177823
Stem Cell Res Ther. 2020 Aug 14;11(1):356
pubmed: 32795359
ACS Appl Mater Interfaces. 2018 Feb 14;10(6):5240-5254
pubmed: 29359912
Mol Ther. 2020 Apr 8;28(4):1200-1213
pubmed: 32097602
Int J Nanomedicine. 2022 Oct 10;17:4725-4741
pubmed: 36246937
Int J Nanomedicine. 2020 Sep 22;15:6917-6934
pubmed: 33061359
Acta Biomater. 2016 Mar;33:242-51
pubmed: 26796208
Cell Death Discov. 2022 Apr 25;8(1):226
pubmed: 35468879
ACS Omega. 2019 Dec 19;4(27):22638-22645
pubmed: 31909348
Redox Biol. 2021 Apr;40:101849
pubmed: 33486152
Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2935-2943
pubmed: 31002144
J Bone Joint Surg Am. 2021 Apr 21;103(8):728-740
pubmed: 33411465
Mol Ther Nucleic Acids. 2020 Dec 10;23:565-576
pubmed: 33510944
Cells. 2019 Dec 11;8(12):
pubmed: 31835680
Neurochem Res. 2018 Nov;43(11):2165-2177
pubmed: 30259257
ACS Biomater Sci Eng. 2020 Mar 9;6(3):1590-1602
pubmed: 33455380
J Transl Med. 2015 Sep 19;13:308
pubmed: 26386558
J Arthroplasty. 2020 Jun;35(6S):S46-S49
pubmed: 32008769
Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111671
pubmed: 33545836
Int J Nanomedicine. 2020 Aug 11;15:5911-5926
pubmed: 32848396
Acta Biomater. 2019 Mar 15;87:296-306
pubmed: 30690207
Front Pharmacol. 2021 Sep 29;12:724256
pubmed: 34658863
Acta Biomater. 2015 Jul;20:147-154
pubmed: 25841346
Cell Death Dis. 2018 Feb 13;9(2):218
pubmed: 29440630
Redox Biol. 2021 May;41:101915
pubmed: 33662874
Stem Cell Res Ther. 2013 Apr 25;4(2):39
pubmed: 23680102
Mater Sci Eng C Mater Biol Appl. 2021 Mar;122:111877
pubmed: 33641893
Int J Pharm. 2019 Apr 20;561:244-264
pubmed: 30851391
Stem Cells Dev. 2018 Apr 1;27(7):456-465
pubmed: 29415626
Nanomedicine. 2016 Apr;12(3):655-664
pubmed: 26586551
Mater Sci Eng C Mater Biol Appl. 2018 Nov 1;92:1041-1060
pubmed: 30184728
Orthop Surg. 2019 Oct;11(5):770-776
pubmed: 31464084
Nat Commun. 2022 Jul 7;13(1):3919
pubmed: 35798730
Polymers (Basel). 2021 Feb 14;13(4):
pubmed: 33672891
Acta Pharmacol Sin. 2017 Jun;38(6):754-763
pubmed: 28392567
J Arthroplasty. 2020 May;35(5):1333-1338
pubmed: 32067897
Small Methods. 2021 Feb;5(2):e2000920
pubmed: 34927892
Biomaterials. 2017 Jan;115:128-140
pubmed: 27889664

Auteurs

Jie Xie (J)

Department of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Yihe Hu (Y)

Department of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Weiping Su (W)

Department of Orthopaedics, The 3rd Xiangya Hospital, Central South University, Changsha, China.

Sijie Chen (S)

Department of Ultrasound Diagnosis, Second Xiangya Hospital, Central South University, Changsha, China.

Jiahao Wang (J)

Department of Orthopedics, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, Hunan, China.

Shuailong Liang (S)

Department of Orthopedics, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, Hunan, China.

Mingyu Chen (M)

Department of Ultrasound Diagnosis, Second Xiangya Hospital, Central South University, Changsha, China.

Haoyi Wang (H)

Department of Orthopedics, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, Hunan, China.

Tianliang Ma (T)

Department of Orthopedics, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, Hunan, China. tianliangma@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH